Customizable bead-based platform for EV surface protein immunocapture and detection in plasma
Preprint
Abstract
Extracellular vesicles (EVs) are increasingly recognized as valuable biomarkers for liquid biopsy because they carry molecular signatures that reflect their cells of origin. However, EV isolation remains a challenge, and existing EV immunocapture platforms are constrained by nonspecific binding, limited flexibility, and insufficient sensitivity. Here, we present a customizable bead-based platform for the isolation and detection of specific EV populations directly from plasma. The platform combines bead-immobilized capture antibodies with fluorescent detection antibodies, enabling sensitive and multiplexed EV profiling. Optimization of bead conjugation chemistry improved antibody immobilization and reduced nonspecific background signals, enhancing assay specificity and performance. Using breast cancer-derived EVs expressing fluorescent protein, we demonstrate the detection of tumor-derived EVs in plasma at concentrations as low as 1 × 10 9 EVs/ml. Furthermore, the assay distinguished HER2- and TROP2-high from low EV populations, demonstrating its ability to detect clinically relevant differences in biomarker expression. The workflow is compatible with direct EV analysis in the unprocessed plasma samples, thereby reducing sample preparation requirements and assay complexity. These findings establish a sensitive, flexible, and scalable platform for EV biomarker analysis. The approach overcomes several limitations of current commercial bead-based technologies and may facilitate the development of customizable multiplexed EV-based assays for cancer detection, patient stratification, and disease monitoring.Keywords
This publication has 36 references indexed in Scilit:
- Self-Contained Lateral-Flow Microfluidic Bead-Based Assay for Rapid Quantification of Early-Stage Kidney BiomarkersAnalytical Chemistry, 2026
- Extracellular Vesicles in Autoimmune Diseases: From Diagnostic Biomarkers to Engineered TherapeuticsAdvanced Science, 2026
- Challenges and Opportunities in State‐of‐the‐Art Proteomics Analysis for Biomarker Development From Plasma Extracellular VesiclesProteomics, 2025
- Extracellular Vesicles as Diagnostic Metrics for Cardiovascular Disease: Where We are and How to Achieve in ClinicsJournal of Cardiovascular Translational Research, 2025
- Comprehensive Comparison of Methods for Isolation of Extracellular Vesicles from Human PlasmaJournal of Proteome Research, 2025
- Natural and Bioengineered Extracellular Vesicles in Diagnosis, Monitoring and Treatment of CancerACS Nano, 2025
- Extracellular vesicles carry distinct proteo-transcriptomic signatures that are different from their cancer cell of originiScience, 2022
- Isolation of extracellular vesicles with combined enrichment methodsJournal of Chromatography B, 2021
- Bead‐Based Extracellular Vesicle Analysis Using Flow CytometryAdvanced Biosystems, 2020
- Tumor Heterogeneity at Protein Level as an Independent Prognostic Factor in Endometrial CancerTranslational Oncology, 2014